Ozempic. Wegovy. Rybelsus. These brand names of the medication semaglutide (a GLP-1) have recently been having quite the moment in the spotlight. From social media influencers and celebrities to publications and news outlets, it seems everyone has been talking about this \u201cmiracle drug.\u201d Following increased exposure and curiosity among the general population about semaglutide, there\u2019s been an influx of non-science-backed headlines and misinformation spread across the internet. Any time a new medication enters the market, evidence-based education is crucial for consumers to understand what these medications can and cannot do.
Many people are searching for the elusive quick fix, but does it actually exist? What are the implications, and how do nutrition and lifestyle factors come into play? As part of our commitment to educating our community, we\u2019re shedding light on this very relevant and timely topic in the latest episode of Stronger U Radio.
Manager of Nutrition Content and Innovation Gianna Masi, RD, sat down with NIH-funded principal investigator and board-certified primary care nurse practitioner Dr. Tina Sadarangani, Ph.D. to debunk the myths and set the record straight (based on fact, not fiction) around semaglutide and weight loss. Dr. Tina has an impressive background and brings a wealth of experience in the medical field. She\u2019s also an assistant professor in the NYU Grossman School of Medicine\u2019s Department of Population Health. Her research program is underscored by a profound commitment to advancing the health of minoritized populations and targeting health disparities.
Tune into this evidence-based conversation for answers to many of the most common questions, such as: